US EditionPublished • loading... • Updated
Obesity treatments Wegovy and Mounjaro Surpass Cancer Drug Keytruda in Sales
Summary by businesskorea.co.kr
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Obesity treatments Wegovy and Mounjaro Surpass Cancer Drug Keytruda in Sales
A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly. (REUTERS) Global obesity treatment drug sales last year surpassed the immune cancer drug Keytruda, which had maintained the top position for an extended period, for the first time. Analysts suggest that the global blockbuster pharmaceutical landscape, previously centered on cancer drugs, has entered a turning point of reorganiza…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
